Form 4 · Filed Jun 10, 2026, 07:07 PM UTC
EBS/Emergent BioSolutions Inc.
Glessner Coleen — EVP, Quality & Ethics, and CPL
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | F | other | 2,018 | $8 | $16,144 | 202,201 |
Source: SEC EDGAR raw filing ↗ · Accession 0001919170-26-000016